Bio-Rad Laboratories, Inc. (BIO-B)

Select a metric from the list below to chart it

Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Revenue
2,132.7
2,175.0
2,019.4
2,068.2
2,160.2
2,289.4
2,311.7
2,545.6
2,922.5
2,802.2
Revenue % Chg.
3.1%
2.0%
-7.2%
2.4%
4.4%
6.0%
1.0%
10.1%
14.8%
-4.1%
Cost of Revenue
954.2
996.5
897.8
930.1
972.8
1,066.3
1,054.7
1,107.8
1,281.9
1,234.9
Cost of Revenue % Chg.
4.3%
4.4%
-9.9%
3.6%
4.6%
9.6%
-1.1%
5.0%
15.7%
-3.7%
Gross Profit
1,178.5
1,178.5
1,121.7
1,138.1
1,187.4
1,223.2
1,257.0
1,437.8
1,640.7
1,567.3
Gross Profit % Chg.
2.1%
0.0%
-4.8%
1.5%
4.3%
3.0%
2.8%
14.4%
14.1%
-4.5%
Gross Profit Margin
55.3%
54.2%
55.5%
55.0%
55.0%
53.4%
54.4%
56.5%
56.1%
55.9%
Gross Profit Margin % Chg.
-0.9%
-1.9%
2.5%
-0.9%
-0.1%
-2.8%
1.8%
3.9%
-0.6%
-0.4%
R&D Expenses
211.0
220.3
193.0
205.9
250.3
199.2
202.7
226.6
271.7
256.9
R&D Expenses % Chg.
-1.4%
4.4%
-12.4%
6.7%
21.6%
-20.4%
1.8%
11.8%
19.9%
-5.4%
Selling, General, & Admin Expenses
798.1
808.2
762.0
816.7
808.9
834.8
824.6
800.3
879.6
827.8
Selling, General, & Admin Expenses % Chg.
16.9%
1.3%
-5.7%
7.2%
-1.0%
3.2%
-1.2%
-3.0%
9.9%
-5.9%
Operating Income
169.5
150.0
166.7
53.2
116.7
-103.3
229.7
411.0
489.4
482.6
Operating Income % Chg.
-34.1%
-11.5%
11.2%
-68.1%
119.3%
78.9%
19.1%
-1.4%
Operating Income Margin
7.9%
6.9%
8.3%
2.6%
5.4%
-4.5%
9.9%
16.1%
16.7%
17.2%
Operating Income Margin % Chg.
-36.1%
-13.2%
19.7%
-68.8%
110.0%
62.5%
3.7%
2.8%
Total Other Income/Expenses Net
-57.1
-18.4
-20.9
-11.6
-18.8
616.0
2,031.4
4,496.7
4,948.7
-5,186.9
Total Other Income/Expenses Net % Chg.
66.5%
67.7%
13.2%
44.2%
62.0%
229.8%
121.4%
10.1%
Income Before Tax
112.4
131.6
145.8
41.6
97.8
512.7
2,261.1
4,907.6
5,438.1
-4,704.3
Income Before Tax % Chg.
-49.6%
17.1%
10.9%
-71.5%
135.3%
424.2%
341.0%
117.0%
10.8%
Income Before Tax Margin
5.3%
6.0%
7.2%
2.0%
4.5%
22.4%
97.8%
192.8%
186.1%
-167.9%
Income Before Tax Margin % Chg.
-51.1%
14.8%
19.4%
-72.2%
125.3%
394.6%
336.8%
97.1%
-3.5%
Income Tax Expense
34.6
42.7
32.8
13.4
-24.4
147.0
502.4
1,101.4
1,192.2
1,076.7
Income Tax Expense % Chg.
-41.5%
23.5%
-23.3%
-59.0%
241.7%
119.2%
8.3%
-9.7%
Net Income
77.8
88.8
113.1
28.1
122.2
365.6
1,758.7
3,806.3
4,245.9
-3,627.5
Net Income % Chg.
-52.5%
14.2%
27.3%
-75.1%
334.7%
199.1%
381.0%
116.4%
11.6%
Net Income Margin
3.6%
4.1%
5.6%
1.4%
5.7%
16.0%
76.1%
149.5%
145.3%
-129.5%
Net Income Margin % Chg.
-53.9%
12.0%
37.1%
-75.7%
316.2%
182.2%
376.4%
96.5%
-2.8%
Weighted Avg. Shares Out
28.6
28.9
29.2
29.4
29.7
29.8
29.8
29.8
29.8
29.8
Weighted Avg. Shares Out % Chg.
1.0%
1.0%
1.1%
0.9%
0.7%
0.6%
0.0%
-0.3%
0.1%
EPS
2.7
3.1
3.9
1.0
3.9
12.1
58.9
127.9
142.6
-121.8
EPS % Chg.
-54.5%
13.2%
25.6%
-75.2%
303.1%
212.7%
387.0%
117.0%
11.6%
Weighted Avg. Shares Out Dil
28.9
29.1
29.4
29.6
30.0
30.2
30.2
30.2
30.2
29.8
Weighted Avg. Shares Out Dil % Chg.
0.9%
0.8%
0.9%
0.8%
1.3%
0.6%
-0.1%
-0.1%
-1.2%
EPS Diluted
2.7
3.1
3.9
1.0
3.8
11.9
58.3
126.2
140.8
-121.8
EPS Diluted % Chg.
-54.5%
13.4%
26.2%
-75.3%
302.1%
212.6%
388.0%
116.6%
11.6%
Interest Income
13.4
13.5
10.1
14.7
19.1
26.6
30.5
18.2
18.9
Interest Income % Chg.
17.5%
0.7%
-25.2%
45.5%
29.9%
39.3%
14.7%
-40.3%
3.8%
Interest Expense
61.3
22.1
21.7
21.9
21.9
24.0
23.4
21.9
1.6
38.1
Interest Expense % Chg.
19.9%
-63.9%
-2.0%
1.2%
-0.1%
9.3%
-2.3%
-6.6%
-92.9%
2357.4%
EBIT
64.5
122.9
134.3
34.3
95.0
515.3
2,268.2
4,904.0
5,455.5
-4,742.4
EBIT % Chg.
-64.8%
90.5%
9.2%
-74.4%
176.8%
442.5%
340.2%
116.2%
11.2%
EBIT Margin
3.0%
5.7%
6.6%
1.7%
4.4%
22.5%
98.1%
192.6%
186.7%
-169.2%
EBIT Margin % Chg.
-65.8%
86.8%
17.6%
-75.0%
165.0%
411.8%
335.9%
96.3%
-3.1%
Depreciation & Amortization
147.2
149.9
131.8
142.9
148.7
138.1
134.2
138.1
133.8
137.3
Depreciation & Amortization % Chg.
12.9%
1.8%
-12.1%
8.4%
4.1%
-7.1%
-2.8%
2.9%
-3.1%
2.6%
EBITDA
211.7
272.8
266.1
177.2
243.7
653.4
2,402.4
5,042.1
5,589.3
-4,605.1
EBITDA % Chg.
-32.5%
28.9%
-2.5%
-33.4%
37.5%
168.1%
267.7%
109.9%
10.9%
EBITDA Margin
9.9%
12.5%
13.2%
8.6%
11.3%
28.5%
103.9%
198.1%
191.2%
-164.3%
EBITDA Margin % Chg.
-34.5%
26.4%
5.0%
-35.0%
31.7%
153.0%
264.1%
90.6%
-3.4%